MCF2L (MCF.2 cell line derived transforming sequence like)

2003-02-01  

Identity

HGNC
LOCATION
13q34
LOCUSID
ALIAS
ARHGEF14,DBS,OST
FUSION GENES

Other Information

Locus ID:

NCBI: 23263
MIM: 609499
HGNC: 14576
Ensembl: ENSG00000126217

Variants:

dbSNP: 23263
ClinVar: 23263
TCGA: ENSG00000126217
COSMIC: MCF2L

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000126217ENST00000261963H3BLT1
ENSG00000126217ENST00000375597O15068
ENSG00000126217ENST00000375604O15068
ENSG00000126217ENST00000375608O15068
ENSG00000126217ENST00000397017H7BYP9
ENSG00000126217ENST00000397021A2A639
ENSG00000126217ENST00000397024A2A3G7
ENSG00000126217ENST00000397030O15068
ENSG00000126217ENST00000397036A2A3H1
ENSG00000126217ENST00000409954B7ZBR9
ENSG00000126217ENST00000413354H7C2S1
ENSG00000126217ENST00000420013H7C275
ENSG00000126217ENST00000421756O15068
ENSG00000126217ENST00000423251A2A640
ENSG00000126217ENST00000433807X6RE72
ENSG00000126217ENST00000439475H0Y7A3
ENSG00000126217ENST00000441756H0Y519
ENSG00000126217ENST00000442625F8WBK7
ENSG00000126217ENST00000453297H0Y4M6
ENSG00000126217ENST00000473345M0R393
ENSG00000126217ENST00000486806M0R1J7
ENSG00000126217ENST00000535094O15068

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Signal TransductionREACTOMER-HSA-162582
Signalling by NGFREACTOMER-HSA-166520
p75 NTR receptor-mediated signallingREACTOMER-HSA-193704
Cell death signalling via NRAGE, NRIF and NADEREACTOMER-HSA-204998
NRAGE signals death through JNKREACTOMER-HSA-193648
Signaling by Rho GTPasesREACTOMER-HSA-194315
Rho GTPase cycleREACTOMER-HSA-194840
Signaling by GPCRREACTOMER-HSA-372790
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (12/13) signalling eventsREACTOMER-HSA-416482

References

Pubmed IDYearTitleCitations
345929392021LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis.9
345929392021LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis.9
317329562020miR-140-3p exhibits repressive functions on preosteoblast viability and differentiation by downregulating MCF2L in osteoporosis.7
317329562020miR-140-3p exhibits repressive functions on preosteoblast viability and differentiation by downregulating MCF2L in osteoporosis.7
290396102017Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.8
290396102017Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.8
258989232016A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.6
258989232016A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.6
265846422015Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874.12
265846422015Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874.12
226154572012Genetic contribution to radiographic severity in osteoarthritis of the knee.8
226154572012Genetic contribution to radiographic severity in osteoarthritis of the knee.8
218715952011A variant in MCF2L is associated with osteoarthritis.57
218715952011A variant in MCF2L is associated with osteoarthritis.57
199110112010Mutation of ARHGAP9 in patients with coronary spastic angina.0

Citation

Dessen P

MCF2L (MCF.2 cell line derived transforming sequence like)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/41316/tumors-explorer/humanGenome